Evotec SE (EUR)
EVT
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range24.17 | 24.45
52-Wk Range- | -
Last Close24.42
Mkt Cap (m)-
Dividend yield-
ISINDE0005664809
Volume0.00
Exchange VenueETR

Company Profile

Evotec AG is a drug discovery and development company. It provides integrated drug discovery services and alliances to the pharmaceutical and biotechnology industry.

Key Information
Price/Earning90.44
Price/Book7.55
Price/Sales7.94
P/CF44.46
Rev Growth (3 year avg)39.48
EPS Growth (3 year avg)0.08
Operating Margin % 16.69
Net Margin %8.53
Return on Equity8.45
Debt/Equity0.97

Documents

Annual Report
en 31/12/2016

Please refer to the below issuer website for further documents.

http://www.evotec.com

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)89.50127.68164.51257.63375.41446.44
Operating Income (m)2.14-2.5336.7538.6862.7974.51
Net Income (m)-6.9816.5227.5324.2684.1738.07
Basic EPS-0.050.130.200.170.570.25
Avg. Diluted Shares Outstanding (m)131.29137.63132.51151.61150.31149.73
Balance Sheet
EUR201420152016201720182019
Current Assets (m)125.30166.94169.24180.25249.77469.53
Non Current Assets (m)99.30121.60182.13487.02522.11711.38
Total Assets (m)224.60288.54351.37667.27771.881,180.91
Current Liabilities (m)33.0756.4073.39245.78196.28178.96
Total Liabilities (m)------
Total Equity (m)158.38185.50213.04330.76424.00477.03
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)-3.8015.6567.3610.83156.2442.22
Capital Expenditure (m)-5.28-11.50-10.15-17.59-27.87-31.91
Figures are quoted in EUR unless stated otherwise
-0.06 (-0.25%)
24.36
Last Price